TOKSIK GEPATIT SHAROITIDA BIOLOGIK FAOL MODDALARNING JIGAR BIOKIMYOVIY JARAYONLARIGA TA’SIRI

Authors

  • Otaxonova Mohinur Bahodir qizi,Mamajanov Muhtorjon Murodullayevich Impuls tibbiyot instituti, Morfologiya kafedrasi o‘qituvchisi,Impuls tibbiyot instituti, PhD, dotsent, katta o‘qituvchi

Keywords:

toksik gepatit, jigar, biologik faol moddalar, oksidlovchi stress, antioksidantlar, glutation, gepatotsit, aminotransferazalar, bilirubin, mitoxondrial disfunksiya.

Abstract

Mazkur tezisda toksik gepatit sharoitida biologik faol moddalarning jigar biokimyoviy jarayonlariga ta’siri zamonaviy ilmiy adabiyotlar asosida tahlil qilinadi. Jigar hujayralarining toksik shikastlanishida oksidlovchi stress, glutation tizimi faoliyatining buzilishi, mitoxondrial disfunksiya, lipidlarning peroksidlanishi va yallig‘lanish reaksiyalarining ahamiyati yoritiladi. Antioksidant xususiyatga ega birikmalar, xususan, glutation tizimini qo‘llab-quvvatlovchi moddalar hamda ayrim vitaminlarning ehtimoliy biokimyoviy ta’sir mexanizmlari ko‘rib chiqiladi. Shuningdek, alaninaminotransferaza, aspartataminotransferaza, ishqoriy fosfataza, bilirubin va boshqa laboratoriya ko‘rsatkichlarining diagnostik ahamiyati tahlil qilinadi. Tezis xulosalari e’lon qilingan ilmiy manbalarga asoslangan bo‘lib, mualliflarning alohida tajriba natijalari sifatida talqin qilinmasligi lozim.

References

[1] European Association for the Study of the Liver (EASL). EASL Clinical Practice Guidelines: Drug-induced liver injury. Journal of Hepatology. 2019;70(6):1222–1261. DOI: 10.1016/j.jhep.2019.02.014. 1222–1261-betlar.

[2] Andrade R.J., Aithal G.P., Björnsson E.S., Kaplowitz N., Kullak-Ublick G.A., Larrey D., Karlsen T.H. va boshqalar. EASL Clinical Practice Guidelines: Drug-induced liver injury. Journal of Hepatology. 2019;70(6):1222–1261. 1222–1261-betlar.

[3] Jaeschke H., McGill M.R., Ramachandran A. Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity. Drug Metabolism Reviews. 2012;44(1):88–106. 88–106-betlar.

[4] Begriche K., Massart J., Robin M.A., Borgne-Sanchez A., Fromenty B. Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver. Journal of Hepatology. 2011;54(4):773–794. 773–794-betlar.

[5] Chalasani N.P., Hayashi P.H., Bonkovsky H.L., Navarro V.J., Lee W.M., Fontana R.J. ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury. The American Journal of Gastroenterology. 2014;109(7):950–966. 950–966-betlar.

[6] McGill M.R., Jaeschke H. Mechanistic biomarkers in acetaminophen-induced hepatotoxicity and acute liver failure: from preclinical models to patients. Expert Opinion on Drug Metabolism & Toxicology. 2014;10(7):1005–1017. 1005–1017-betlar.

[7] Chughlay M.F., Kramer N., Spearman C.W., Werfalli M., Cohen K. N-acetylcysteine for non-paracetamol drug-induced liver injury: a systematic review. British Journal of Clinical Pharmacology. 2016;81(6):1021–1029. 1021–1029-betlar.

[8] Navarro V.J., Khan I., Björnsson E., Seeff L.B., Serrano J., Hoofnagle J.H. Liver injury from herbal and dietary supplements. Hepatology. 2017;65(1):363–373. 363–373-betlar.

[9] Kaplowitz N. Biochemical and cellular mechanisms of toxic liver injury. Seminars in Liver Disease. 2002;22(2):137–144. 137–144-betlar.

[10] Ramachandran A., Jaeschke H. Acetaminophen hepatotoxicity: a mitochondrial perspective. Advances in Pharmacology. 2019;85:195–219. 195–219-betlar.

[11] Bernal W., Wendon J. Acute liver failure. The New England Journal of Medicine. 2013;369(26):2525–2534. 2525–2534-betlar.

[12] National Institute of Diabetes and Digestive and Kidney Diseases. Clinical Course and Diagnosis of Drug Induced Liver Disease. In: LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bethesda, MD: NIDDK; 2012–. Yangilangan: 2019-yil 4-may. Elektron manba, “Clinical Pattern”, “Injury Pattern” va “Exclusion of Other Diagnoses” bo‘limlari.

[13] National Institute of Diabetes and Digestive and Kidney Diseases. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bethesda, MD: NIDDK; 2012–. Elektron ma’lumotlar bazasi, dori vositalari va biologik faol qo‘shimchalarning gepatotoksikligi haqidagi bo‘limlar.

[14] Fontana R.J., Liou I., Reuben A., Suzuki A., Fiel M.I., Lee W. va boshqalar. AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury. Hepatology. 2023;77(3):1036–1065. 1036–1065-betlar.

Downloads

Published

2026-10-11

Conference Proceedings Volume

Section

Articles

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.